Naville D, Lebrethon M C, Kermabon A Y, Rouer E, Benarous R, Saez J M
INSERM U307, Hôpital Debrousse, Lyon, France.
FEBS Lett. 1993 Apr 26;321(2-3):184-8. doi: 10.1016/0014-5793(93)80104-3.
The classical concept of human adrenal physiology indicates that only glomerulosa cells are the target of A-II. Herein, we demonstrated that cultured human adrenal fasciculata-reticularis cells were also responsive to this hormone. Indeed, these cells contained high affinity (Kd = 0.9-1.1 nM) and low capacity (8,000-13,000 sites/cell) A-II receptors, and more than 95% of them were of the type-1. These AT1 receptors are functional since A-II was able to increase cortisol production after 48 h of treatment. These effects were inhibited by losartan, an AT1 antagonist, but not by CGP42112A, an AT2 antagonist. The expression of the type-1 A-II receptor mRNA was detected in the whole adrenal in both adult and fetus, and in cultured human adrenal fasciculata-reticularis cells. In these cells A-II negatively regulated AT1 receptor mRNA, and this effect was also mediated through the AT1 receptor subtype.
人类肾上腺生理学的经典概念表明,只有球状带细胞是血管紧张素II(A-II)的作用靶点。在此,我们证明培养的人肾上腺束状带-网状带细胞也对这种激素有反应。实际上,这些细胞含有高亲和力(解离常数Kd = 0.9 - 1.1 nM)和低容量(8000 - 13000个位点/细胞)的A-II受体,其中超过95%为1型。这些1型血管紧张素受体(AT1受体)具有功能,因为在处理48小时后A-II能够增加皮质醇的产生。这些作用被AT1拮抗剂氯沙坦抑制,但不被AT2拮抗剂CGP42112A抑制。在成人和胎儿的整个肾上腺以及培养的人肾上腺束状带-网状带细胞中均检测到1型A-II受体mRNA的表达。在这些细胞中,A-II对AT1受体mRNA起负调节作用,并且这种作用也是通过AT1受体亚型介导的。